Conservative management of stage T2 or T3a bladder cancer with deep transurethral resection followed by four cycles of chemotherapy

Uygur M., Yaman I., Altug U., Erol D.

BRITISH JOURNAL OF UROLOGY, vol.78, no.2, pp.201-204, 1996 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 78 Issue: 2
  • Publication Date: 1996
  • Doi Number: 10.1046/j.1464-410x.1996.01099.x
  • Journal Name: BRITISH JOURNAL OF UROLOGY
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.201-204
  • Acibadem Mehmet Ali Aydinlar University Affiliated: Yes

Abstract

Objective To evaluate the efficacy of the conservative management of stage T2 and T3a bladder cancer with deep (radical) transurethral resection (TUR) followed by four cycles of chemotherapy with methotrexate, vinblastine, epirubicin and cisplatin (MVEC) and its impact on bladder preservation and tumour recurrences.